Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children - Sorbonne Université Access content directly
Journal Articles Neuro-Oncology Year : 2020

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children

Abstract

Abstract Background Previous pilot studies have shown the feasibility of preoperative chemotherapy in patients with medulloblastoma, but benefits and risks compared with initial surgery have not been assessed. Methods Two therapeutic strategies were retrospectively compared in 92 patients with metastatic medulloblastoma treated at Gustave Roussy between 2002 and 2015: surgery at diagnosis (n = 54, group A) and surgery delayed after carboplatin and etoposide-based neoadjuvant therapy (n = 38, group B). Treatment strategies were similar in both groups. Results The rate of complete tumor excision was significantly higher in group B than in group A (93.3% vs 57.4%, P = 0.0013). Postoperative complications, chemotherapy-associated side effects, and local progressions were not increased in group B. Neoadjuvant chemotherapy led to a decrease in the primary tumor size in all patients; meanwhile 4/38 patients experienced a distant progression. The histological review of 19 matched tumor pairs (before and after chemotherapy) showed that proliferation was reduced and histological diagnosis feasible and accurate even after neoadjuvant chemotherapy. The 5-year progression-free and overall survival rates were comparable between groups. Comparison of the longitudinal neuropsychological data showed that intellectual outcome tended to be better in group B (the mean predicted intellectual quotient value was 6 points higher throughout the follow-up). Conclusion Preoperative chemotherapy is a safe and efficient strategy for metastatic medulloblastoma. It increases the rate of complete tumor excision and may improve the neuropsychological outcome without jeopardizing survival.
Fichier principal
Vignette du fichier
noaa083.pdf (3.59 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Licence : CC BY NC - Attribution - NonCommercial

Dates and versions

hal-04485466 , version 1 (01-03-2024)

Licence

Attribution - NonCommercial

Identifiers

Cite

Léa Guerrini-Rousseau, Rachid Abbas, Sophie Huybrechts, Virginie Kieffer-Renaux, Stéphanie Puget, et al.. Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children. Neuro-Oncology, 2020, 22 (11), pp.1686-1695. ⟨10.1093/neuonc/noaa083⟩. ⟨hal-04485466⟩
19 View
3 Download

Altmetric

Share

Gmail Facebook X LinkedIn More